HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

Tackling AMR and medicine shortages in the EU

How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.

What is the Europe Canna Expo?

Kristina Spionjak discusses what will happen at Europe Canna Expo 2020, and reflects on opportunities for the medical cannabis industry.

A focus on the rise of cannabidiol (CBD)

George Thomas, Managing Director of Goodbody Botanicals, part of Sativa Group Plc, turn our thoughts towards the undoubted rise of cannabidiol (CBD).

What are the most common myths about CBD?

Here, Paul Segal, chairman and co-founder of Symtomax, details what the most common myths about CBD are.

Why is it so hard to determine which CBD products to buy?

Jade Mansfield from British CBD Company, explains why it is so hard to know which CBD products to buy since its growth in popularity.

Canada: Promoting social science and humanities research

Promoting social science and humanities research in universities and colleges across Canada is charted here by Open Access Government.

The pharmaceutical industry in Europe

Here, we focus on some of the key issues facing the pharmaceutical industry throughout Europe.

Medical use of cannabinoids and marijuana

In this article, Dr Gerry Morrow shares his thoughts on the medical use of cannabinoids and marijuana.

The medical cannabis market in Denmark & Europe

Investment Manager at the Ministry of Foreign Affairs of Denmark, Michael Prytz, charts the rapid development of the medical cannabis market in Europe and provides a look at the Danish model in this vein.

What next for the UK’s cannabis laws?

John Binns, Partner at BCL Solicitors LLP looks at the UK’s cannabis laws and how they could be improved.

From Cannabis flower to final products: Extractions for Phytopharmaceuticals

Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.

Medicinal cannabis: What the UK can learn from Denmark

Spectrum Therapeutics UK lifts the lid here on a pilot analysis of medicinal cannabis use that will run in Denmark until January 2022.

SSPC: Training the next generation of highly skilled pharmaceutical scientists and engineers

Louise O’Neill from SSPC, the SFI Research Centre for Pharmaceuticals, underlines the importance of training the next generation of highly skilled pharmaceutical scientists and engineers in Ireland.

The value of accreditation in the cannabis industry

Chris Gunning, General Manager – Accreditation Services at A2LA, discusses the value of accreditation in today’s cannabis industry.

Data science: Providing medication and creating a more efficient NHS

Rich Pugh, Chief Data Scientist at Mango Solutions, discusses how data science can be used for good, with a particular focus on the provision of medication and helping create a more efficient NHS.

NHS could save £651 million with community pharmacy service

Researchers have assessed a community pharmacy service and calculated that this would save the NHS around £651 million.

Cystic fibrosis drugs agreement secured by NHS England

NHS England has announced it has secured a definitive cystic fibrosis drugs agreement with Vertex Pharmaceuticals, to use all three of their UK-licensed medicines.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders